CENCORA, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CENCORA, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- CENCORA, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $649.00K, a 91.54% decline year-over-year.
- CENCORA, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $7.60M, a 6.29% decline year-over-year.
- CENCORA, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $6.52M, a 3.82% increase year-over-year.
- CENCORA, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $93.91M, a 52.75% decline from fiscal 2021.
- CENCORA, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $198.75M, a 24.58% increase from fiscal 2020.
- CENCORA, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $159.53M, a 109.27% increase from fiscal 2019.
- CENCORA, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $76.23M, a 44.94% decline from fiscal 2018.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-05 | $14.77M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $649.00K 10-Q · filed 2026-05-06 | $21.60M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $7.60M 10-Q · filed 2026-02-04 | $28.62M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-09-30 | $6.52M derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $29.13M 8-K · filed 2026-02-10 |
| 2025-06-30 | $6.83M 10-Q · filed 2026-08-05 | $28.89M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $7.67M 10-Q · filed 2026-05-06 | $34.99M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $8.11M 10-Q · filed 2026-02-04 | $35.02M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-09-30 | $6.28M derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $37.84M 8-K · filed 2026-02-10 |
| 2024-06-30 | $12.93M 10-Q · filed 2025-08-06 | $42.63M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $7.70M 10-Q · filed 2025-05-07 | $48.07M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | $10.93M 10-Q · filed 2025-02-05 | $50.22M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-09-30 | $11.07M derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $61.15M 8-K · filed 2026-02-10 |
| 2023-06-30 | $18.37M 10-Q · filed 2024-07-31 | $60.04M derived: sum of 4 quarters · filed 2024-11-26 |
| 2023-03-31 | $9.85M 10-Q · filed 2024-05-01 | $52.65M derived: sum of 4 quarters · filed 2024-11-26 |
| 2022-12-31 | $21.86M 10-Q · filed 2024-01-31 | $76.84M derived: sum of 4 quarters · filed 2024-11-26 |
| 2022-09-30 | $9.96M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-26 | $93.91M 10-K · filed 2024-11-26 |
| 2022-06-30 | $10.98M 10-Q · filed 2023-08-02 | $118.41M derived: sum of 4 quarters · filed 2023-11-21 |
| 2022-03-31 | $34.04M 10-Q · filed 2023-05-02 | $141.40M derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-12-31 | $38.94M 10-Q · filed 2023-02-01 | $179.47M derived: sum of 4 quarters · filed 2023-11-21 |
| 2021-09-30 | $34.45M derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-21 | $198.75M 10-K · filed 2023-11-21 |
| 2021-06-30 | $33.97M 10-Q · filed 2022-08-03 | $186.08M derived: sum of 4 quarters · filed 2022-11-22 |
| 2021-03-31 | $72.11M 10-Q · filed 2022-05-04 | $213.10M derived: sum of 4 quarters · filed 2022-11-22 |
| 2020-12-31 | $58.22M 10-Q · filed 2022-02-02 | $197.64M derived: sum of 4 quarters · filed 2022-11-22 |
| 2020-09-30 | $21.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-22 | $159.53M 10-K · filed 2022-11-22 |
| 2020-06-30 | $60.99M 10-Q · filed 2021-08-04 | $159.12M derived: sum of 4 quarters · filed 2021-11-23 |
| 2020-03-31 | $56.64M 10-Q · filed 2021-05-05 | $115.40M derived: sum of 4 quarters · filed 2021-11-23 |
| 2019-12-31 | $20.11M 10-Q · filed 2021-02-04 | $73.95M derived: sum of 4 quarters · filed 2021-11-23 |
| 2019-09-30 | $21.37M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-23 | $76.23M 10-K · filed 2021-11-23 |
| 2019-06-30 | $17.27M 10-Q · filed 2020-08-05 | $65.81M derived: sum of 4 quarters · filed 2020-11-19 |
| 2019-03-31 | $15.19M 10-Q · filed 2020-05-07 | $60.81M derived: sum of 4 quarters · filed 2020-11-19 |
| 2018-12-31 | $22.40M 10-Q · filed 2020-01-30 | $131.28M derived: sum of 4 quarters · filed 2020-11-19 |
| 2018-09-30 | $10.95M derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-19 | $138.46M 10-K · filed 2020-11-19 |
| 2018-06-30 | $12.27M 10-Q · filed 2019-08-01 | |
| 2018-03-31 | $85.66M 10-Q · filed 2019-05-02 | |
| 2017-12-31 | $29.57M 10-Q · filed 2019-01-31 | |
| 2017-09-30 | $102.92M 10-K · filed 2019-11-19 | |
| 2016-09-30 | $74.77M 10-K · filed 2018-11-20 | |
| 2015-09-30 | $105.88M 10-K · filed 2017-11-21 | |
| 2014-09-30 | $81.56M 10-K · filed 2016-11-22 | |
| 2013-09-30 | $114.49M 10-K · filed 2015-11-24 | |
| 2011-09-30 | $115.82M 10-K · filed 2011-11-22 | |
| 2010-09-30 | $111.68M 10-K · filed 2011-11-22 | |
| 2009-09-30 | $20.56M 10-K · filed 2011-11-22 | |
| 2008-09-30 | $71.22M 10-K · filed 2010-11-23 | |
| 2007-09-30 | $75.02M 10-K · filed 2009-11-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |